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ABSTRACT
Objectives: Knowledge of a study population’s
similarity to the target population allows researchers to
assess the generalisability of their results. Often
generalisability is assessed through a comparison of
baseline characteristics between individuals who did
and did not respond to an invitation to participate in
a study. In this prospective population-based cohort,
we broadened this assessment by comparing
participants with all individuals from a chronic disease
register who satisﬁed the study eligibility criteria but
for a number of reasons, such as the absence of
consent to be approached for research purposes, did
not participate.
Methods: Data are from the Living with Diabetes
Study, a population-based cohort of individuals
diagnosed with diabetes mellitus, which commenced
in Queensland, Australia in 2008. Individuals were
sampled from a federally-funded diabetes register. We
compared the characteristics of 3951 study
participants with 10488 non-participants (individuals
who were invited to participate but declined) and with
129900 non-study individuals on the register who did
not participate in the study.
Results: Study participants were more likely than non-
study registrants to be male, aged 50e69, have type 2
diabetes non-insulin requiring, be recently registered
and be non-indigenous Australians. Study participants
were more likely than non-participants to be aged
50e69, have type 1 diabetes and be non-indigenous
Australians.
Conclusions: The interpretation of a study’s
generalisability can alter depending on which non-
participating group is compared with participants.
When assessing generalisability, participants should
be compared with the largest possible group of non-
participating individuals. When sampling from
a disease register, researchers should be wary of the
inﬂuence of research consent procedures on the
register’s coverage.
INTRODUCTION
Population-based cohort studies are essential
when studying chronic diseases such as dia-
betes mellitus, as they can offer a compre-
hensive understanding of disease trajectory
over time and allow for multiple subgroup
analyses.
1 2 However, the utility of each
study’s ﬁndings depends on whether the
results are sufﬁciently generalisable to the
population under investigation. The extent
of a study’s generalisability, or external
validity, depends on how representative of
the target population the study’s participants
are.
3e5 Since information on the target
population is often unavailable, investiga-
tions concerning the generalisability of
population-based cohorts, including those
concerning diabetes, have focused on the
comparison of baseline characteristics
between study participants and non-partici-
pants to assess how similar or different they
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ARTICLE SUMMARY
Article focus
- To assess the similarity between study partici-
pants sampled from a chronic disease register
and registrants who did not participate in the
study.
- To assess whether the differences between
participants and registrants who did not partic-
ipate are similar to the differences between
participants and individuals who were invited to
participate but declined.
Key messages
- The generalisability of a study should be
assessed by comparing participants with the
largest possible group of non-participating
individuals.
- When sampling from a disease register,
researchers should be wary of the inﬂuence of
research consent procedures on the register’s
coverage.
Strengths and limitations of this study
- Information is available for all individuals regis-
tered with the chronic disease register.
- The chronic disease register from which study
participants were recruited has high coverage of
the target population.
- Only aggregated data were available for regis-
trants who were not invited to participate in the
study.
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6e9 However, a high degree of similarity between
participants and non-participants does not necessarily
mean results arising from the study will have good
generalisability, as these two groups as a whole might not
fully represent the target population due to coverage
error.
10 11 The extent to which ﬁndings are generalisable
can be assessed by comparing the study participants
with the largest possible subset of all diseased individuals
in the population being studied, other than partici-
pants.
12 13 The characteristics of this larger group can be
accessed through databases such as national chronic
disease registers.
6
Chronic disease registries are increasingly used to
recruit participants to cohort studies. One purported
advantage of this is to ensure generalisability to the
target population.
14e16 In recent years, however, legisla-
tive reform concerning privacy issues has been intro-
duced in many countries, including Australia, which has
restricted research related access to these databases
without an individual’s consent.
17 It is possible that this
may seriously limit the usefulness of chronic disease
registers for epidemiological research.
18 19 This study
investigates the generalisability of one Australian
register, the National Diabetes Services Scheme (NDSS)
and explores whether chronic disease registrants who
agreed to participate in a research study have similar
characteristics to registrants who satisﬁed the inclusion
criteria but did not participate. We also compare the
characteristics of participants with the characteristics of
individuals who were invited to participate but declined.
METHODS
The Living with Diabetes Study (LWDS) is a population-
based cohort study that began in Queensland, Australia
in 2008. An individual was eligible to participate in the
study if they had doctor diagnosed type 1 or 2 diabetes,
were aged at least 18 years and had a valid Queensland
postal address. Individuals were randomly sampled from
a federally-funded register of Australians with diabetes,
the NDSS, managed by a non-governmental organisation
called Diabetes Australia. The NDSS’s coverage of
Queenslanders with diabetes is estimated to be between
80% and 90%.
20 Since 2001, individuals joining the
NDSS have been asked whether they would like to be
informed about opportunities to participate in research.
Only those who consented to be contacted for research
purposes were eligible to be invited to participate in the
LWDS. The LWDS sampling design speciﬁed three target
locations of policy interest to be oversampled: an outer
metropolitan area, a new suburban development and
a coastal agricultural community. All eligible individuals
from the three locations were invited to participate;
approximately one in six eligible individuals from the
rest of Queensland were invited to participate.
Selected individuals were invited to participate in
the LWDS via a mailed questionnaire. Information was
collected on demographic and socio-economic charac-
teristics, health behaviour, and health and psychological
status. Strategies to maximise participation included
reminder cards, telephone calls and replacement surveys.
We categorised registrants into four mutually exclusive
groups: participants, non-participants, non-sampled
consenting registrants and non-consenting registrants. A
participant was deﬁned as an individual who agreed to
participate in the LWDS. A non-participant was deﬁned
as an individual who was invited to participate in the
LWDS but declined. A non-sampled consenting regis-
trant was deﬁned as an individual who agreed to partic-
ipate in the LWDS but was not selected during the
sampling process. A non-consenting registrant was
deﬁned as an individual who had not agreed to be
contacted for research purposes. Initially, participants
were compared to non-participants (the reference
group). For a secondary comparative analysis, the refer-
ence group was expanded to comprise all registrants who
were not study participants. This expanded reference
group was deﬁned as non-study registrants (ﬁgure 1).
Available individual-level information on participants
and non-participants consisted of sex, age, diabetes
status, year of NDSS registration, postcode and indige-
nous status. Postcodes were matched to the Australian
Bureau of Statistics’ index of relative socio-economic
disadvantage (Socio-Economic Indexes for Areas, SEIFA)
ranking, and categorised into tertiles.
21 Due to privacy
and research consent issues, only covariate aggregate
data were available for individuals not invited to partici-
pate in the study. Ethics approval was obtained from The
University of Queensland’s Behavioural and Social
Sciences Ethical Review Committee.
Data analysis
For participants, non-participants and non-study regis-
trants, we calculated the frequency (percentage) of
individuals in each category for sex, age (18e49, 50e69,
70+ years), diabetes status (type 2 non-insulin requiring;
Figure 1 Living with Diabetes Study registrants categorised
by participation status.
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Generalisability of disease registerstype 2 insulin requiring, type 1), registration year
(2001e2003, 2004e2005, 2006e2008), SEIFA tertile and
indigenous status. Initially, we used logistic regression
analyses to compare participants with non-participants
on a univariable basis. We then ﬁtted a series of multi-
variate logistic regression models in order to investigate
the impact of potential confounders and obtain fully
adjusted associations. Analyses were weighted according
to the sampling scheme. As individual-level data were
not available for all individuals in the reference group of
non-study registrants, we used univariable logistic
regression with aggregate data to compare participants
with non-study registrants. Results for each of the
analyses are presented in table 1 as ORs and 95% CIs.
RESULTS
On 30 June 2008 there were 133851 registrants in the
NDSS who satisﬁed the LWDS entry criteria, of whom
75347 (56.3%) did not consent to participate in any
research and were excluded (ﬁgure 2). Of the remaining
58504 registrants, 14439 were invited to participate in
the LWDS, 3951 of whom agreed. Complete aggregate
information was available for all variables except for
registration year and SEIFA. Due to NDSS procedural
changes and invalid postcodes, data for 56264 registra-
tion years and 1711 postcodes were not available for the
analyses.
Table 1 shows the results of comparisons of 3951
participants with 10488 non-participants, and of partic-
ipants with 129900 non-study registrants. After adjusting
for all covariates, individuals were less likely to partici-
pate in the LWDS if they were younger (OR 0.63; 95% CI
0.55 to 0.71) or older (0.89; 0.81 to 0.99) than those
aged 50e69 years and had identiﬁed themselves as being
indigenous Australians (0.61; 0.48 to 0.77). Those who
had type 1 diabetes (1.50; 1.19 to 1.90) were more likely
to participate in the study. A sensitivity analysis was
conducted to speciﬁcally investigate the effect of
potential confounders. The analyses were re-run six
times with one covariate excluded on each occasion. The
only effect estimate seen to vary substantially was dia-
betes status. In the model adjusted across all covariates
except age (not shown in table 1), the odds of being
a participant if an individual had type 1 diabetes was 1.13
(0.91 to 1.42) greater than if an individual had type 2
diabetes and did not require insulin, while for the fully
adjusted model it was 1.50 (1.19 to 1.90).
The comparative analysis between participants and
non-study registrants (table 1) shows a number of asso-
ciational differences when compared to the previous
multivariate analysis. The most noticeable is the rela-
tionship between participation and diabetes status, as it
varies in both strength and direction. These analyses
show that compared to those with type 2 diabetes who
were not insulin reliant, individuals with type 2 diabetes
and insulin reliant (0.71; 0.66 to 0.77) and type 1 dia-
betes (0.28; 0.24 to 0.32) were less likely to participate. In
addition, the association between participation status
and sex was also strengthened, with females less likely
than males to be participants (0.91; 0.86 to 0.97). There
was no evidence of an association between participation
and SEIFA, but this was not the case with year of NDSS
registration, as registration between 2006 and 2008 was
positively associated with participation (1.15; 1.06 to
1.24), while registration between 2004 and 2005 was
inversely associated (0.89; 0.81 to 0.97). Associations
between participation and the covariates of age and
indigenous status were similar in direction and magni-
tude to those found by the multivariate analysis, except
for those aged at least 70 years, which strengthened
inversely (0.48; 0.45 to 0.52).
DISCUSSION
The differences observed on the comparisons between
participants and non-participants, and between partici-
pants and non-study registrants, conﬁrm that the extent
of a study’s generalisability should be established by
comparing study participants to a group of individuals
which best represents the target population. In this
study, those who agreed to participate in the LWDS were
signiﬁcantly different from the non-study registrants
over a number of characteristics, with the most notable
being diabetes status. Those with type 2 diabetes who
were insulin requiring, were less likely to participate in
the LWDS. Individuals were less likely to be participants
if they were insulin requiring, with the odds of partici-
pation being 29% less likely for those with type 2 dia-
betes who were insulin requiring, and 72% less likely for
those with type 1 diabetes. This parallels the research
literature, which suggests that those less healthy are
more likely to be non-responders than those in better
health.
22e24 However, this was not the case when
participants were compared to non-participants, which
showed a strong association also, but was directionally
opposite to the previous result; the adjusted odds of
those with type 1 diabetes participating were 50% greater
than those who had type 2 diabetes but were not insulin
requiring. Such a result indicates that those with type 1
diabetes, although less likely to be invited due to consent
issues relating to age at diagnosis,
25 were more likely to
participate once invited.
Age and Australian indigenous status were also signif-
icantly associated with study participation, with age also
having a negative confounding effect on the LWDS
participationediabetes status relationship. Unlike the
inﬂuence of diabetes status, these associations were
similar in direction and strength for both comparative
analyses.
Although these results are consistent with the litera-
ture,
5 26 27 they raise the issue of representativeness.
Disparities in sample balance have the potential to impact
adversely on the estimation of population parameters
such as prevalence and incidence metrics.
92 8 e30
Our initial comparative analysis was between partici-
pants and non-participants, and relied solely on infor-
mation from those invited to participate in the study.
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Generalisability of disease registersThis analysis failed to identify an important association
between diabetes status and participation.
This was due to the underrepresentation of individuals
with type 1 diabetes by a factor of more than 3 in the
group of non-participants (4.6%) when compared to
registrants not invited to participate in the study
(15.4%). Such underrepresentation is the consequence
of type 1 diabetes being predominately diagnosed
during childhood and the NDSS consent protocol,
20
which does not include a systematic updating of consent
status at the age of 18 among those registered as a child.
Mandatory informed consent, including parental, not
only has a negative effect on participation rates overall,
but also weakens the representativeness of the study
sample by producing unbalanced subgroups among the
study participants.
25 31 32 This was the case because
research consent was not a necessary criterion for an
individual to be considered a registrant.
The results of our study should be interpreted within
the context of some limitations. First, the generalisability
of any study’s ﬁndings to the target population is very
much dependent on register coverage and the quality of
its database.
16 33 34 Increased levels of coverage and data
quality lessen the likelihood of biased sample
estimates.
35e37 The coverage of the NDSS is estimated to
be between 80% and 90%, which is higher than most
diabetes registers,
20 33 thus giving it the potential to
produce sampling frames of a higher data quality than
Figure 2 Participation ﬂowchart
for the Living with Diabetes Study.
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Generalisability of disease registersmost. Second, in analyses such as these which only utilise
one time-point, there is an inability to maximise the
information provided by time varying determinants of
non-response such as age.
23 38 39 Third, due to unavail-
ability of individual-level data for registrants not invited
to participate in the study, it was not possible to
complete a comparative analysis between participants
and non-study registrants that isolated the independent
covariate effects after adjustment. It is possible that
individual data would have resulted in the associations
between participation and a number of covariates being
more similar to those found when non-participants were
used as the reference group.
Our ﬁndings illustrate that the standard procedure of
comparing study participants and non-participants in
assessing a study’s generalisability can be compromised
by the issue of research consent when disease registers
are used as a source of recruitment. Whenever possible,
a clearer assessment should be sought by extending this
standard practice to a secondary analysis by sourcing the
largest possible reference group that is inclusive of non-
participants. For prospective population-based cohort
studies, researchers should endeavour to source a group
that contains all potential participants who satisﬁed
inclusion criteria but have not been able to participate.
As ﬁndings can be inﬂuenced by the issue of research
consent, where available, chronic disease registers should
be utilised fully in any assessment of generalisability.
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